Daniel Janse
Direttore/Membro del Consiglio presso Triumvira Immunologics USA, Inc.
Profilo
Daniel Janse has held director positions at Isolere Bio, Triumvira Immunologics USA, and EnPlusOne Biosciences.
Posizioni attive di Daniel Janse
| Società | Posizione | Inizio |
|---|---|---|
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Direttore/Membro del Consiglio | - |
EnPlusOne Biosciences, Inc
 EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Isolere Bio, Inc.
 Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
EnPlusOne Biosciences, Inc
EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | Technology Services |
- Borsa valori
- Insiders
- Daniel Janse
